BioGaia AB (publ) (LON: 0GTN)

Market Cap	870.17M
Revenue (ttm)	99.73M
Net Income (ttm)	24.78M
Shares Out	n/a
EPS (ttm)	0.25
PE Ratio	35.12
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	May 8, 2024

Volume	2,548
Average Volume	1,858
Open	115.60
Previous Close	115.90
Day's Range	115.60 - 117.10
52-Week Range	6.94 - 9.88
Beta	0.59
RSI	64.31
Earnings Date	Feb 12, 2025

About BioGaia AB

BioGaia AB (publ), a healthcare company, provides probiotic products worldwide. The company operates through Pediatrics, Adult Health, and Other segments. The Pediatrics segment offers drops, oral rehydration solutions, and gut health tablets, as well as cultures that are used as an ingredient in infant formula. The Adult Health segment provides gut health tablets and oral health lozenges products, as well as cultures, which are used as an ingredient in a licensee’s dairy product. The Other segment provides packaging solutions. It sells its pro...

• Industry: Pharmaceutical Preparations
• Founded: 1990
• Employees: 210
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0GTN

Financial Performance

In 2023, BioGaia AB's revenue was 1.30 billion, an increase of 17.44% compared to the previous year's 1.10 billion. Earnings were 365.35 million, a decrease of -2.25%.

Financial numbers in SEK